Nuvectis Pharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$20.81

+0.59 (+2.92%)

As of Sep 28, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +31.7% upside

Low Target $23.46

Average Target $27.40

High Target $40.51

Current Price $20.81

Current
$20.81

Target
$27.40

$23.46 $27.40 avg $40.51

Scenario Analysis

Bear Case

$23.46

12.7%

Low target

Base Case

$27.40

+31.7%

Avg target

Bull Case

$40.51

+94.7%

High target

Risk/Reward

7.4x

Highly favorable

Price in Context

52-Week High

$29.28

-28.9% from high

52-Week Low

$5.55

+275.0% from low

Target vs 52W High

$27.40

-6.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%